OppenheimerFunds’s Orthofix Medical OFIX Stock Holding History

OppenheimerFunds’s Portfolio OFIX Stock Details OFIX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q1	$277K	Buy	4,918 +662	+16%	+$37.2K	﹤0.01%	1582
2018 Q4	$223K	Sell	4,256 -1,705	-29%	-$97K	﹤0.01%	1692
2018 Q3	$345K	Buy	5,961 +530	+10%	+$29.7K	﹤0.01%	1600
2018 Q2	$309K	Buy	5,431 +601	+12%	+$34.2K	﹤0.01%	1620
2018 Q1	$284K	Sell	4,830 -1,306	-21%	-$73.2K	﹤0.01%	1615
2017 Q4	$336K	Buy	6,136 +73	+1%	+$3.79K	﹤0.01%	1664
2017 Q3	$287K	Sell	6,063 -1,071	-15%	-$50.4K	﹤0.01%	1730
2017 Q2	$331K	Sell	7,134 -856	-11%	-$35.5K	﹤0.01%	1675
2017 Q1	$305K	Buy	+7,990	New	+$296K	﹤0.01%	1708

Other funds holding OFIX

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return

SBH

Segall Bryant & Hamill Chicago, Illinois $8.43B AUM 52.02% 1-Year Est. Return

Ameriprise Minneapolis, Minnesota $495B AUM 43.24% 1-Year Est. Return

HRCM

Hood River Capital Management Palm Beach Gardens, Florida $13.8B AUM 163.97% 1-Year Est. Return

Norges Bank Oslo, Norway $1T AUM

OppenheimerFunds's OFIX Position: Q1 2019 in Review

OppenheimerFunds increased its Orthofix Medical (OFIX) stake by 16% in Q1 2019, buying an estimated $37.2K and bringing the position to 4,918 shares worth $277K. The position accounts for ﹤0.01% of the portfolio, ranked #1582.

OppenheimerFunds first reported a position in OFIX in Q1 2017 and has held it in 9 quarters since. The position peaked at $345K in Q3 2018. 172 funds tracked by Wall St. Rank hold OFIX as of Q1 2019.

OppenheimerFunds held 4,918 shares of Orthofix Medical worth $277K as of Q1 2019.
OppenheimerFunds bought 662 Orthofix Medical shares in Q1 2019, an estimated $37.2K.
Orthofix Medical made up ﹤0.01% of OppenheimerFunds's portfolio in Q1 2019, its #1582 holding.
OppenheimerFunds first reported a position in Orthofix Medical in Q1 2017 and has held it in 9 quarters since.
OppenheimerFunds's Orthofix Medical position peaked at $345K in Q3 2018.
172 funds tracked by Wall St. Rank held Orthofix Medical as of Q1 2019.

Based on OppenheimerFunds's 13F filing for Q1 2019, filed 13 May 2019.